Fig. 1
From: Old drugs, new challenges: reassigning drugs for cancer therapies
A. Repurposing trials are a modest percentage of all oncology clinical trials. B The most popular drugs in repurposing trials (C) and the most popular cancers to be targeted in controlled trails of repurposed drugs. The data were obtained from the ReDO_Trials_DB database and the GlobalData’s Clinical Trials Intelligence Center (December 15, 2023)